A NEW scientific centre for biomedical research will be built in the eastern-Slovak village of Šarišské Michaľany. The Slovak Academy of Sciences (SAV) will build it using an EU grant and additional resources from the state budget.
The centre, to be named the Centre for Research and Development of Immunologically Active Substances will be part of the SAV’s Institute of Virology in Šarišské Michaľany, where SAV already has its detached workstation focusing on biotechnological applications.
In the new labs, SAV researchers will perform applied research focusing on bio-pharmaceuticals, vaccines against virus-induced contagious diseases, and on anti-microbes substances.
The project costs are estimate at €25 million, of which over €21 million will come from EU structural funds and almost €4 million from the state budget.
Compiled by Michaela Terenzani from press reports
The Slovak Spectator cannot vouch for the accuracy of the information presented in its Flash News postings.
27. Jan 2014 at 13:00